Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

156994

registered interest
date	20/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Antibiotics
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to the Government's response to the House of Commons Science and Technology Committee report, Ensuring access to working antimicrobials, Cm, 8919, whether his Department is working on potential alternative pricing and reimbursement mechanisms for novel antibiotics in advance of the conclusion of the O'Neill Review; and what plans he has to explore new funding mechanisms with industry in the interim.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	215487
answer	answer is ministerial correction date of answer 25/11/2014 answer text <p>As part of the United Kingdom’s antimicrobial resistance strategy, we have been working with industry and with other national and international stakeholders on how best to stimulate the development of new antibiotics, diagnostics and potential business models as well as on research into antimicrobial resistance.</p><p> </p><p> </p><p> </p><p>We will continue to explore what can be done to support antimicrobial diagnostics and drug development pending the announcement by the independent Review on Antimicrobial Resistance of its conclusions.</p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 25/11/2014 13:22:48 answering member 4020 label Biography information for George Freeman
tabling member	4056 label Biography information for Nic Dakin

156998

registered interest
date	20/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Drugs: Licensing
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, on what dates since 2 July 2014 he has discussed with charities the use of off-patent drugs for new indications; and what the content of these discussions was.
tabling member constituency	North West Leicestershire
tabling member printed	Andrew Bridgen
uin	215396
answer	answer is ministerial correction date of answer 27/11/2014 answer text <p>Off-patent drugs are those whose patent period has expired and they are widely used in the National Health Service now. Drugs can also be prescribed ‘off-label’ outside of their licensed indication(s) to individual patients where doctors consider it is clinically appropriate to do so. Prescribing decisions are rightly a matter for clinicians in discussion with their patients.</p><p> </p><p> </p><p> </p><p>My Rt. hon. Friend the Secretary of State has had no discussions with charities about the use of off-patent drugs for new indications since 2 July. Officials have had several discussions with the Breast Cancer Campaign covering their views on medicines licences, implementation of National Institute for Health and Care Excellence guidelines and planning the roundtable discussion on adoption of new evidence into clinical practice. There have also been ongoing discussions with Cancer Research UK on the use of aspirin to help prevent certain cancers.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 27/11/2014 17:23:49 answering member 4020 label Biography information for George Freeman
tabling member	4133 label Biography information for Andrew Bridgen

156999

registered interest
date	20/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Transatlantic Trade and Investment Partnership
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what advice or research his Department has commissioned from external bodies on the potential effects on the NHS of the Transatlantic Trade and Investment Partnership.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	215373
answer	answer is ministerial correction date of answer 27/11/2014 answer text <p>While the Department has not commissioned research, we continue to work with the Department for Business, Innovation and Skills, key partners and other stakeholders to ensure our publicly stated position is respected.</p><p> </p><p> </p><p> </p><p>We are aware of concerns about the European Union–United States Transatlantic Trade and Investment Partnership (TTIP) currently being negotiated which are misplaced and inaccurate.</p><p> </p><p> </p><p> </p><p>What we can be absolutely clear on is that this Government will not allow TTIP</p><p> </p><p>negotiations to harm the National Health Service, and any assertion that the agreement will undermine the NHS is both irresponsible and false. Our position is supported by statements from both the European and US negotiators.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 27/11/2014 17:45:56 answering member 4020 label Biography information for George Freeman
tabling member	1506 label Biography information for Andrew Gwynne

157004

registered interest
date	20/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Paracetamol
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the cost to the public purse was of prescriptions issued for paracetamol in England in each of the last two years; and if he will make a statement.
tabling member constituency	Enfield North
tabling member printed	Nick de Bois
uin	215406
answer	answer is ministerial correction date of answer 25/11/2014 answer text <p>Information on the number and net ingredient cost of prescription items for paracetamol<sup>1</sup> dispensed in the community in England is in the table.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>Prescription Items</p><p>(000s)</p></td><td><p>Net Ingredient Cost</p><p>(£000s)</p></td></tr><tr><td><p>2012-13</p></td><td><p>21,963.2</p></td><td><p>73,793.9</p></td></tr><tr><td><p>2013-14</p></td><td><p>22,616.5</p></td><td><p>83,146.6</p></td></tr></tbody></table><p> </p><p><sup>1</sup>Excludes combination medicines. Includes multiple packs per item and a range of formulations, including those produced specific to patient needs</p><p> </p><p><em>Source:</em> Prescription Cost Analysis system provided by the NHS Business Services Authority</p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 215407 question first answered 25/11/2014 17:07:23 answering member 4020 label Biography information for George Freeman
tabling member	4002 label Biography information for Nick de Bois

157005

registered interest
date	20/11/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Paracetamol
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many prescriptions have been issued for paracetamol in England in each of the last two years.
tabling member constituency	Enfield North
tabling member printed	Nick de Bois
uin	215407
answer	answer is ministerial correction date of answer 25/11/2014 answer text <p>Information on the number and net ingredient cost of prescription items for paracetamol<sup>1</sup> dispensed in the community in England is in the table.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>Prescription Items</p><p>(000s)</p></td><td><p>Net Ingredient Cost</p><p>(£000s)</p></td></tr><tr><td><p>2012-13</p></td><td><p>21,963.2</p></td><td><p>73,793.9</p></td></tr><tr><td><p>2013-14</p></td><td><p>22,616.5</p></td><td><p>83,146.6</p></td></tr></tbody></table><p> </p><p><sup>1</sup>Excludes combination medicines. Includes multiple packs per item and a range of formulations, including those produced specific to patient needs</p><p> </p><p><em>Source:</em> Prescription Cost Analysis system provided by the NHS Business Services Authority</p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 215406 question first answered 25/11/2014 17:07:23 answering member 4020 label Biography information for George Freeman
tabling member	4002 label Biography information for Nick de Bois